Virbac SA

Paris Stock Exchange VIRP.PA

Virbac SA Return on Equity (ROE) for the year ending December 31, 2023: 13.47%

Virbac SA Return on Equity (ROE) is 13.47% for the year ending December 31, 2023, a -7.28% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Virbac SA Return on Equity (ROE) for the year ending December 31, 2022 was 14.53%, a -6.91% change year over year.
Virbac SA Return on Equity (ROE) for the year ending December 31, 2021 was 15.61%, a -28.75% change year over year.
Virbac SA Return on Equity (ROE) for the year ending December 31, 2020 was 21.91%, a 120.05% change year over year.
Virbac SA Return on Equity (ROE) for the year ending December 31, 2019 was 9.96%, a 128.01% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Paris Stock Exchange: VIRP.PA

Virbac SA

CEO	Mr. Habib Ramdani
IPO Date	July 7, 1992
Location	France
Headquarters	13e rue LID - BP 27
Employees	5,459
Sector	Consumer Staples
Industries Pet Food

Description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key trends

Past 5 years